Regional Analysis
- North America: The U.S. leads with high PCI volumes, while Canada focuses on coronary care.
- Europe: Germany, France, and the UK drive demand due to advanced cardiology systems.
- Asia Pacific: China sees growth from rising CVD cases, while Japan emphasizes elderly care.
- Rest of the World: Brazil expands cardiac services, and the Middle East invests in diagnostics.
Application Analysis
- Hospitals: Expected growth of 4.3%-6.2%, driven by PCI procedures. Trends focus on real-time imaging.
- Diagnostic Imaging Centers: Projected growth of 4.2%-6.1%, linked to outpatient diagnostics. Developments emphasize portability.
- Academic and Research Institutes: Anticipated growth of 4.4%-6.3%, suited for innovation. Advances prioritize AI integration.
Type Analysis
- Virtual Histology IVUS: Expected growth of 4.4%-6.3%, valued for tissue characterization. Trends highlight 3D visualization.
- iMAP IVUS: Projected growth of 4.3%-6.2%, key for plaque assessment. Advances focus on precision.
- Integrated Backscatter IVUS: Anticipated growth of 4.2%-6.1%, driven by detailed imaging. Innovations emphasize automation.
Key Market Players
Leading firms include Philips, offering Proxis; Boston Scientific Corporation, enhancing IVUS; Canon Medical Systems Corporation, scaling diagnostics; Siemens Healthcare, focusing on imaging; GE Healthcare, boosting precision; Hitachi, advancing ultrasound; Mindray Medical International, targeting affordability; Samsung Medison, innovating in imaging; Chison Medical Technologies, scaling solutions; and Fujifilm, supporting diagnostics.Porter's Five Forces Analysis
- Threat of New Entrants: Moderate, due to high R&D and regulatory barriers, though AI innovators can enter.
- Threat of Substitutes: Low, as IVUS is essential for precise PCI with no direct alternatives.
- Bargaining Power of Buyers: Moderate, with facilities seeking accurate, cost-effective systems, though clinical needs limit options.
- Bargaining Power of Suppliers: Low, with multiple component providers.
- Competitive Rivalry: High, with competition on imaging resolution, AI integration, and cost.
Market Opportunities and Challenges
Opportunities:
- Cardiovascular diseases (17.9 million deaths) and PCI procedures (3 million annually) drive demand.
- Aging populations (2.1 billion over 60 by 2050) boost needs, while high-resolution imaging and AI enhance adoption.
- Minimally invasive trends increase usage.
Challenges:
- High costs of advanced IVUS systems limit access in low-income regions.
- Regulatory delays for AI tech slow growth.
- Limited interventional cardiologists in rural areas restrict expansion.
- Market News
- In April 2024, Provisio Medical’s Provisio IVUS System received FDA clearance for real-time measurements.
- In May 2024, SonoVascular partnered with Lantheus Holdings for the SonoThrombectomy System.
- In October 2023, Evident Vascular launched with USD 35 million for AI-enhanced IVUS technology.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Philips
- Boston Scientific Corporation
- Canon Medical Systems Corporation
- Siemens Healthcare
- GE Healthcare
- Hitachi
- Mindray Medical International
- Samsung Medison
- Chison Medical Technologies
- Fujifilm

